United States of America based
NonExomics apply machine learning technology to discover drugs for diseases arising specifically from non-exom issues. The company integrates all kinds of omics data – genomics, transcriptomics, proteomics – to predict nonexomic proteins and identify disease-causing targets. NonExomics partners with other biopharma organizations to design biomarker assays, identify biomarker candidates, therapeutic targets and drugs.
TechnologiesAI Companies (Drug Discovery)
No pipelines published yet
No services posted yet